<scp>GLP</scp> ‐1 Receptor Agonists in Brazil: Landscape of Consumption, Safety and Regulation
The convergence of escalating demand, widespread off-label use and product falsification requires a coordinated and agile regulatory response. The observed trends suggest significant access disparities driven by economic factors rather than epidemiological need.
Authors
- Angélica Amorim Amato (ORCID: https://orcid.org/0000-0002-8454-5504)
- Hugo de Luca Corrêa (ORCID: https://orcid.org/0000-0002-3080-9391)
- Renato Lopes Hurtado
- Dâmaris Silveira
Institutions
- Universidade de Brasília (BR)
- Universidade Católica de Brasília (BR)
- National Water Agency (BR)
Publication Details
- Journal
- Diabetes Obesity and Metabolism
- Published
- 2026-03-08
- DOI
- https://doi.org/10.1111/dom.70609
- Primary Topic
- Diabetes Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00